Panel Creates MDL for Levaquin Tendon Rupture Claims

WASHINGTON, D.C. - Federal lawsuits alleging injury caused by the antibiotic Levaquin have been transferred to a single judge in Minnesota, despite opposition from the drug's manufacturer that claimed the consolidation was unnecessary. In re Levaquin Products Liability Litigation, MDL No. 1943 (JPML).

The U.S. Judicial Panel on Multidistrict Litigation on June 13 ordered the transfer of 14 cases and six potential tag-along cases filed throughout the country to the U.S. District Court for the District of Minnesota. The panel said that the cases involve common questions of fact and that centralization will serve the convenience of the parties and …